GlaxoSmithKline Pharmaceuticals Limited (GSK Pharma) announced the resignation of Sunder Ramachandran as Head of Commercial Excellence, with effect from January 12, 2024. According to the company’s exchange filing, “we hereby inform you that Mr. Sunder Ramachandran – Head of Commercial Excellence, has tendered his resignation effective from the close of business hours on 12th January…
GlaxoSmithKline Pharmaceuticals Limited (GSK) announced the appointment of Omkar Parnandiwar as Head of Omnichannel, with effect from November 1, 2023. According to the company’s exchange filing, “we hereby inform you that the appointment of Mr. Omkar Parnandiwar, Head of Omnichannel effective 1st November, 2023. He will be part of the Senior Management team of the…
GlaxoSmithKline Pharmaceuticals Limited announced the appointment of Manu Anand as Additional Director on the Board of the company, with effect from May 16, 2022. According to the company’s exchange filing, “Pursuant to Regulation 30 and Schedule Ill (A) (7) of the Listing and Disclosure Requirements Regulations, 2015, we wish to inform you that Board of…
GlaxoSmithKline Pharmaceuticals Limited announced the re-appointment of Sridhar Venkatesh as Managing Director of the company for a period of one year from 1st April 2022 to 31st March 2023. Sridhar Venkatesh is a senior business leader with more than 28 years of diverse experience in pharmaceuticals and healthcare. He joined GSK in 2011 as Head…